Navigation Links
Generic Pharmaceuticals Offer Exciting Growth Opportunities in Tanzania, Reveals Frost & Sullivan
Date:4/16/2009

CAPE TOWN, South Africa, April 16 /PRNewswire/ -- The pharmaceuticals market in Tanzania presents significant growth opportunities for local companies. Generic drug production is driving prices down, resulting in higher uptake.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), Strategic Analysis of the Healthcare Industry in Tanzania, finds that the pharmaceutical market earned revenues of $105.0 million in 2007 and estimates this to reach $188.0 million in 2014.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Patrick Cairns, Corporate Communications, at patrick.cairns@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brief brochure will be sent to you by e-mail.

"Growth in the Tanzanian pharmaceuticals industry will be boosted by the expected decline in drug prices, due to the increased availability of generic drugs," notes Frost & Sullivan Research Analyst Ishe Zingoni. "This would facilitate higher uptake of drugs and promote the local manufacturing industry."

Government support has been crucial in stimulating the infant local pharmaceuticals sector. Localisation of drug manufacturing is driving prices of some drug classes down, and as the industry reaches sufficient economies of scale, prices are predicted to further decrease.

The main restraint in this market is the intensifying level of competition from low cost imports. Local manufacturing is also hindered extensively by the lack of technical skills in production.

"Manufacturers in Tanzania cannot get local expertise and, therefore, rely on Indian and British expatriates for the technical aspects of production," adds Zingoni. "Local employees only focus on packaging and labeling processes."

Some local manufacturers are entering strategic agreements with Thai partners to facilitate technical skills transfer and procure raw materials. Together with their partners, Tanzanian companies are increasingly investing in generating local expertise through training programmes.

Strategic Analysis of the Healthcare Industry in Tanzania is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: Strategic Analysis of the Healthcare Industry of Kenya, Key Infectious Diseases Markets in East Africa, Strategic Analysis of Oncology Services in Key Sub-Saharan African Countries and, Infectious Disease Pharmaceutical Markets in key Sub-Saharan African Countries. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

           Strategic Analysis of the Healthcare Industry in Tanzania
                                   M2F4

    Contact:
    Patrick Cairns
    Corporate Communications - Africa
    P: +27 18 468 2315
    E: patrick.cairns@frost.com

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics
2. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
3. Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
4. GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
5. Consumer, Business and Labor Groups Endorse Bipartisan Senate Bill Authorizing Biogenerics
6. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
7. Prasco Selected as GSKs Generics Marketing and Distribution Agent
8. Thomson Reuters Publishes Pharma Matters White Paper, The Five Myths of Generic Competition
9. Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
10. D&W Fresh Markets, Family Fare and VGs Expand Discounted Generic Drug Program
11. GPhA Praises President Obamas Support for Safe and Affordable Biogenerics as Critical Solution to Americas Ailing Health Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. ... ... ... ... Astellas is a ...
Breaking Medicine Technology: